John J. Boniface, Chief Scientific Officer at SERA PROGNOSTICS, INC. (SERA), sold 4,902 shares at $9.59 ($47K) on 2024-05-08, disclosed to the SEC on 2024-05-10.
Open-market sale of $47k SERA by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SERA | SELL | 2025-12-11 | $4K | — | Filing → |
| SERA | SELL | 2025-11-12 | $20K | — | Filing → |
| SERA | SELL | 2025-09-12 | $4K | — | Filing → |